Proxy Votes Now

Home › Activist investors › Kanen Wealth

Kanen Wealth

Campaign activist. Positions and campaigns from Kanen Wealth’s SEC filings. Updated November 20, 2026.

Filer entities
Kanen Wealth Management LLC
SEC CIK
1681614 (Kanen Wealth Management LLC)
SEC filings
Schedule 13D filings · 13F reports · soliciting material
Latest 13F
Quarter ended Sep 30, 2026, filed Nov 13, 2026: 33 US-listed positions reported; 11 of 1% or more of a company without a 13D are listed below.
13current positions
7new or changed in 90 days; 2 exited
0active campaigns
4campaigns on record

Active campaigns

No active campaign by this definition (see How to read this).

Current positions (13)

CompanyStakeSourceFirst disclosedLast changeSince previous filingFlagsStated intent
Barnes & Noble Education, Inc. 9.54%3,308,081 shares 13F, quarter ended Sep 30, 2026filed Nov 13, 2026; % of shares outstanding as of Sep 3, 2026 Oct 16, 2024 Decreased Nov 13, 2026 ▼ 0.21 pts Decreased 13F: none stated
Inspired Entertainment, Inc. 8.69%2,289,979 shares 13F, quarter ended Sep 30, 2026filed Nov 13, 2026; % of shares outstanding as of Nov 2, 2026 Nov 14, 2022 Decreased Nov 13, 2026 ▼ 1.00 pts Decreased 13F: none stated
Fossil Group, Inc. 5.11%3,022,258 shares 13F, quarter ended Sep 30, 2026filed Nov 13, 2026; % of shares outstanding as of Aug 5, 2026 Feb 18, 2026 Increased Nov 13, 2026 ▲ 3.63 pts Increased 13F: none stated
Zevia PBC 4.26%2,908,236 shares 13F, quarter ended Sep 30, 2026filed Nov 13, 2026; % of shares outstanding as of Mar 31, 2026 May 18, 2026 Increased Nov 13, 2026 ▲ 0.32 pts Increased 13F: none stated
Entravision Communications Corporation 3.86%3,547,800 shares 13F, quarter ended Sep 30, 2026filed Nov 13, 2026; % of shares outstanding as of Mar 31, 2026 Aug 13, 2026 Increased Nov 13, 2026 ▲ 0.48 pts Increased 13F: none stated
Apyx Medical Corporation 3.68%1,551,235 shares 13F, quarter ended Sep 30, 2026filed Nov 13, 2026; % of shares outstanding as of Nov 4, 2026 Aug 13, 2026 Increased Nov 13, 2026 ▲ 3.50 pts Increased 13F: none stated
TheRealReal, Inc. 1.52%1,899,304 shares 13F, quarter ended Sep 30, 2026filed Nov 13, 2026; % of shares outstanding as of Oct 22, 2026 Sep 6, 2024 Increased Nov 13, 2026 ▲ 0.22 pts Increased 13F: none stated
ONE Group Hospitality, Inc. 14.1%4,348,419 shares Schedule 13D/A, filed Jul 10, 2025 Jun 11, 2025 Decreased Jul 10, 2025 ▼ 1.10 pts — Standard Item 4 language
Outdoor Holding Company 9.99%11,594,794 shares 13F, quarter ended Sep 30, 2026filed Nov 13, 2026; % of shares outstanding as of Aug 5, 2026 Jun 13, 2025 — ▲ 0.08 pts — 13F: none stated
Allot Ltd. 9.8%4,793,041 shares Schedule 13D, filed Jun 25, 2026 Jun 25, 2026 — — — Seeks changes or engagement
Data I/O Corporation 8.07%839,421 shares 13F, quarter ended Sep 30, 2026filed Nov 13, 2026; % of shares outstanding as of Jul 31, 2026 Aug 24, 2021 — 0.00 pts — 13F: none stated
Xponential Fitness, Inc. 4.56%1,702,669 shares 13F, quarter ended Sep 30, 2026filed Nov 13, 2026; % of shares outstanding as of Mar 31, 2026 Feb 18, 2026 — 0.00 pts — 13F: none stated
Immersion Corporation 3.05%1,013,700 shares 13F, quarter ended Sep 30, 2026filed Nov 13, 2026; % of shares outstanding as of Sep 8, 2026 Oct 16, 2024 — 0.00 pts — 13F: none stated

Stake: the latest 13D’s percent of the class (the largest single reporting person’s, as filed), or for a 13F the reported shares as a percent of the company’s shares outstanding on the date shown. Since previous filing: the change in percentage points against the investor’s previous 13D on the company, or its previous 13F.

Stated intent (13D Item 4)

Item 4 of a Schedule 13D (“Purpose of Transaction”) is where the investor states its plans. The label is a plain reading of that text; the excerpt is quoted from the filing.

Allot Ltd. · Seeks changes or engagement

“The Reporting Persons recently engaged with the Issuer's management and Board of Directors regarding opportunities for value creation. Following the Issuer's announcement on June 23, 2026 that it has authorized a share repurchase program of up to $40 million of the Shares, the Reporting Persons no longer hold securities of the Issuer…”

Item 4 in the Schedule 13D filed Jun 25, 2026.

Campaigns are compiled from SEC filings (13D, proxy contest filings and settlement 8-Ks); campaigns run without SEC filings, e.g. by public letter below the 5% threshold, may not appear.

Past campaigns (4)
CompanyOutcome or last statusDateFirst filingHighest stageFilingsMeeting / votes
Quipt Home Medical Corp. Stake reported below 5% May 28, 2025 Jan 10, 2025 — latest (4) —
Orion Energy Systems, Inc. Settled (agreement with the company) Mar 9, 2023 Mar 9, 2023 — latest (1) —
1847 Goedeker Inc. Settled (agreement with the company) Oct 21, 2021 Oct 21, 2021 — latest (1) —
Meet Group, Inc. Settled (agreement with the company) Jan 9, 2018 Jan 9, 2018 — latest (1) —
Past positions (4)
CompanyLast stakeSourceOutcomeDate
Arhaus, Inc. 1.56% 13F, quarter ended Jun 30, 2026filed Aug 13, 2026; % of shares outstanding as of Mar 31, 2026 Not in the latest 13F Nov 13, 2026
SKYX Platforms Corp. 1.36% 13F, quarter ended Jun 30, 2026filed Aug 13, 2026; % of shares outstanding as of Jul 31, 2026 Not in the latest 13F Nov 13, 2026
EGAIN Corp 4.4% Schedule 13D/A, filed Nov 13, 2025 Reported below 5% in a 13D/A Nov 13, 2025
Quipt Home Medical Corp. 4.4% Schedule 13D/A, filed May 28, 2025 Reported below 5% in a 13D/A May 28, 2025

How large managers voted in Kanen Wealth’s proxy contests (meetings since July 2023)

Fund votes come from Form N-PX filings, which this site holds from July 1, 2023 (meetings through June 30, 2026; later meetings appear when the managers file their next N-PX); earlier contests and campaigns that settled before a vote are listed under the activist’s campaigns.

No proxy contest has gone to a vote since July 1, 2023.

Track record

How each campaign on record ended, as read from the filings: settlements disclosed in the company’s 8-K or the investor’s 13D, contested votes (8-K Item 5.07), withdrawals and 13D amendments below 5%.

4Settlement
Outcome of each campaign (4)
CompanyOutcomeDetailDateFirst filing
Quipt Home Medical Corp. Settlement agreement with the company Mar 4, 2025 Jan 10, 2025
Orion Energy Systems, Inc. Settlement agreement with the company Mar 9, 2023 Mar 9, 2023
1847 Goedeker Inc. Settlement agreement with the company Oct 21, 2021 Oct 21, 2021
Meet Group, Inc. Settlement agreement with the company Jan 9, 2018 Jan 9, 2018

Share price after the first 13D

The change in the company’s closing share price from the first trading day on or before the investor’s first Schedule 13D to the latest close, and to 6 and 12 months after it, beside the S&P 500 (SPY) over the same dates. This is a price change after a filing date: it is not attributed to the investor, and it is not the investor’s return. Coverage: 0 of 4 13D positions have prices (the site’s daily price history starts November 10, 2025, and covers only listed tickers it tracks).

Settlement terms

Terms of the cooperation agreements, read by rules from the company’s Form 8-K (or the investor’s 13D where it describes the agreement). Each term is quoted from the filing; terms a rule did not find are not listed, so a missing term is not evidence that the agreement lacks it.

Quipt Home Medical Corp. · Mar 4, 2025 · Voting commitment
Orion Energy Systems, Inc. · Mar 9, 2023 · Directors named
1847 Goedeker Inc. · Oct 21, 2021 · Directors named, Voting commitment
Meet Group, Inc. · Jan 9, 2018 · Directors named, Voting commitment

Other disclosed holders around the same time

Filings by other activists on this list (their first 13D or 13F on the company) and by other holders of 5% or more (Schedule 13D or 13G) dated within 180 days of Kanen Wealth’s first disclosure in the same company. They are listed together by date only; nothing here says the holders act together.

Entravision Communications Corporation · Kanen Wealth first disclosed Aug 13, 2026 · 3 other filings
HolderFormDateStake
Gate City Capital Management, LLC Schedule 13G Feb 17, 2026 13.6%
American Century Investment Management, Inc. Schedule 13G May 1, 2026 11.1%
Alexandra Seros Schedule 13G May 21, 2026 10.0%
Arhaus, Inc. · Kanen Wealth first disclosed Aug 13, 2026 · 3 other filings
HolderFormDateStake
Wasatch Advisors LP Schedule 13G Mar 5, 2026 4.7%
Voya Financial, Inc. Schedule 13G May 5, 2026 5.1%
Vanguard Capital Management Schedule 13G Jul 31, 2026 5.0%
Zevia PBC · Kanen Wealth first disclosed May 18, 2026 · 1 other filing
HolderFormDateStake
Bubble Holdings, LLC Schedule 13D Oct 29, 2026 16.1%
Xponential Fitness, Inc. · Kanen Wealth first disclosed Feb 18, 2026 · 1 other filing
HolderFormDateStake
Voss Value Master Fund, LP Schedule 13D Mar 4, 2026 18.2%
EGAIN Corp · Kanen Wealth first disclosed Jun 5, 2025 · 1 other filing
HolderFormDateStake
BlackRock, Inc. Schedule 13G Feb 5, 2025 4.9%
Quipt Home Medical Corp. · Kanen Wealth first disclosed Jan 10, 2025 · 1 other filing
HolderFormDateStake
Forager Fund, L.P. Schedule 13D Dec 11, 2024 9.7%
Barnes & Noble Education, Inc. · Kanen Wealth first disclosed Oct 16, 2024 · 3 other filings
HolderFormDateStake
Greenhaven Road Investment Management, L.P. Schedule 13D May 17, 2024 9.9%
Toro 18 Holdings LLC Schedule 13D Jun 12, 2024 —
Bernard Selz Schedule 13G Jan 6, 2025 3.4%
TheRealReal, Inc. · Kanen Wealth first disclosed Sep 6, 2024 · 1 other filing
HolderFormDateStake
Philotimo Fund, LP Schedule 13D Nov 1, 2024 6.8%

How to read this

Flags (last 90 days)
New first disclosed in the last 90 days. Increased / Decreased shares up or down in a 13D/A or 13F filed in that time. Below 5% a 13D/A reported less than 5%, the reporting threshold. Exited a 13D/A reported no shares, or the investor’s 13F no longer lists a company it listed before.
Active campaign
A contested meeting at which the investor is soliciting proxies is still to be held; or in the last 12 months it filed a proxy-contest document (PREC14A, DEFC14A or DFAN14A soliciting material), stated in a 13D that it nominated directors, filed a letter or presentation to the board or shareholders, or stated public demands in a 13D — and no settlement, withdrawal, contested vote or 13D below 5% is dated on or after the latest such filing. Status is the furthest step since then: Public demands in a 13D < Public letter or soliciting material < Nominations made < Proxy contest filed.
Sources and limits
SEC EDGAR only. 13D data covers filings since June 2023; 13F reports are quarterly and filed up to 45 days after the quarter, and do not show swaps, most options or non-US holdings. Settlements are cooperation agreements disclosed in the company’s 8-K or stated in the investor’s 13D; board seats are read from the 8-K. Text marked Summary of the filing is checked against the filing, whose words are quoted beside it. Nothing on this page predicts what the investor will do.